Listen on the go
CORRECT!
Next question
touchENDOCRINOLOGY touchENDOCRINOLOGY

Start Learning

Touch Loading image
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
JOURNALS
Start Learning
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
Stastical analysis indication diabetes mellitus .generative ai
JOURNALS
Start Learning
Forty-four Years of the UK Prospective Diabetes Study: Legacy Effect and Beyond
JOURNALS
Start Learning
Foreword: touchREVIEWS in Endocrinology 21.1
CONFERENCE HUB
Start Learning
MiniMed 780G safe and effective for children 2-6 years with type 1 diabetes
touchPANEL DISCUSSION
Start Learning
Integrating treatment advances for alpha-mannosidosis into effective MDT care
CE/CME ACCREDITED
JOURNALS
Start Learning
Use of Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes
JOURNALS
Start Learning
The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review
Endometriosis and Uterine Diseases
JOURNALS
Start Learning
The 11th Annual SEUD Congress: Modern Management of Endometriosis and Uterine Diseases
JOURNALS
Start Learning
Q&A with Dr Lindsey Gaston: touchENDOCRINOLOGY Future Leader 2025
3D Rendered Medical Illustration of Male Anatomy - The Pancreas.
JOURNALS
Start Learning
Diabetes Care and Education: A Look Backward and Forward

to view Favourites, Keep Notes and Track CME Credits

Favourites
Celebrating 60 years: Standout moments from EASD 2024
View
SOUL results indicate oral semaglutide reduces MACE risk by 14% in adults with T2D
View
The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19
View
A Clinical Review of Continuous Glucose Monitoring in the Hospital Setting
View
What to expect from IDS 2024?
View
WAPO launches Blogs & Vlogs 2025 to spotlight global pituitary health challenges
View
The next frontier in managing obesity with or without T2D: The role of novel combinations
View
Early Identification of Patients At Risk for MASH With Fibrosis
View
The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review
View
Q&A with Prof Lung Yi Mak: touchENDOCRINOLOGY Future Leader 2025
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup